Targets/Mutation | Drug |
NTRK Fusion | Entrectenib |
Larotrectinib | |
BRAF V600E | Dabrafenib plus trametinib |
EGFR exon 20 insertion | Osimertinib |
Poziotinib | |
Mobocertinib (TAK-788) | |
Compound 1A | |
Hsp90 (EGFR exon 20 insertion) | Luminespib |
EGFR and MET | JNJ-6372 |
METexon14 | Crizotinib |
Glesatinib | |
Tepotinib | |
Capmatinib | |
Telisotuzumab vedotin | |
KRAS G12C | AMG 510 |
MRTX849 | |
RET | Cabozantinib |
Vandetanib | |
LOXO-292 (Selpercatinib) | |
Pralsetinib | |
HER2 | Trastuzumab and Trastuzumab emtansine (T-DM1) |
Trastuzumab Deruxtecan (DS-8201a) | |
Dacomitinib | |
Afatinib | |
Pyrotinib | |
FGFR | AZD4547 |